Invasive therapies in women
| Autor: | Eftihia Sbarouni |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
medicine.medical_specialty
MINOCA= myocardial infarction with nonobstructive coronary arteries SCAD= Spontaneous coronary artery dissection HCM=hypertrophic cardiomyopathy STEMI= ST-segment elevation myocardial infarction primary prevention Cardiology Review Article heart disease list: CVD=cardiovascular disease AH=Arterial Hypertension Coronary artery disease HF=heart failure AF=atrial fibrillation Text mining gender medicine Humans HFpEF=heart failure with preserved ejection fraction HFrEF=heart failure with reduced ejection fraction Women PPCM=peripartum cardiomyopathy DCM=dilated cardiomyopathy Intensive care medicine business.industry cardiovascular TAVR= transcatheter aortic valve replacement SAVR=surgical aortic valve replacement medicine.disease LDL= low density lipoprotein ACS= acute coronary syndrome Cardiovascular Diseases CAD=coronary artery disease AAOCA= anomalous aortic origin of a coronary artery PAD=peripheral artery disease PAH=primary pulmonary hypertension ARD=Autoimmune rheumatic disease Female FH= Familial hypercholesterolemia DM=Diabetes mellitus Cardiology and Cardiovascular Medicine business coronary artery disease secondary prevention |
| Zdroj: | Hellenic Journal of Cardiology |
| ISSN: | 2241-5955 |
| Popis: | The perception that women represent a low risk population for cardiovascular (CV) disease (CVD) needs to be reconsidered. Starting from risk factors, women are more likely to be susceptible to unhealthy behaviors and risk factors that have different impact on CV morbidity and mortality compared to men. Despite the large body of evidence as regards the effect of lifestyle factors on the CVD onset, the gender-specific effect of traditional and non-traditional risk factors on the prognosis of patients with already established CVD has not been well investigated and understood. Furthermore, CVD in women is often misdiagnosed, underestimated and undertreated. Women also experience hormonal changes from adolescence till elder life that affect CV physiology. Unfortunately, in most of the clinical trials women are under-represented, leading to limited knowledge of CV and systemic impact effects of several treatment modalities on women’s health. Thus, in this consensus a group of female Cardiologists from the Hellenic Society of Cardiology present the special features of CVD in women: the different needs in primary and secondary prevention, as well as therapeutic strategies, that may be implemented in daily clinical practice in order to eliminate underestimation and undertreatment of CVD in female population. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|